跳至主要内容
临床试验/CTRI/2023/07/055218
CTRI/2023/07/055218尚未招募Unknown

A Randomised Open label Clinical Study comparing the efficacy & safety of Superbioavailable Itraconazole(SBITZ)and Conventional Itraconazole(CITZ) in the treatment of Glabrous Dermatophytosis at a tertiary care hospital

Dr NagiReddy Apoorva Reddy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Males and females greater than 18yrs of age who are clinically proven cases of Tinea Cruris,Tinea Corporis along with proven positive KOH mount
  • 2.Patient with chronic dermatophytosis without any antifungal therapy for at least 3 weeks prior to study

排除标准

  • 1.Age greater than 60
  • 2.Patients with Tinea involving the Non Glabrous Area (Tinea capitis,Tinea unguium,Tinea Mannum,Tinea Pedis.
  • 3.Patients with any significant medical illness such as Diabetes,Cardiac,Liver and Chronic Kidney diseases,Immunocompromised conditions
  • 4.Pregnant and lactating females
  • 5.Children
  • 6.Patients who have documented intolerance ,allergy or hypersensitivity to Itraconazole

研究者

发起方
Dr NagiReddy Apoorva Reddy

相似试验